Funding Rounds
Cytovale Series B round, October 2019
CytovaleCytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.
Summary
Stage: Series B
Raised Amount: $15.00M
Raised Date: 2019-10-01
